Navigation Links
Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
Date:2/17/2009

on for its product candidates and its discoveries. These and other risks which may impact management's expectations are described in greater detail under the caption "Risk Factors" in the company's quarterly report on Form 10-Q for the quarter ended September 30, 2008 as filed with the Securities and Exchange Commission (SEC) and other filings that the company makes with the SEC.

All forward-looking statements reflect the company's expectations only as of the date of this release and should not be relied upon as reflecting the company's views, expectations or beliefs at any date subsequent to the date of this release. Idenix anticipates that subsequent events and developments may cause these views, expectations and beliefs to change. However, while Idenix may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.

                          IDENIX PHARMACEUTICALS, INC.

                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                     (IN THOUSANDS, EXCEPT PER SHARE DATA)

                                   (UNAUDITED)

                                     Three Months Ended      Years Ended
                                         December 31,        December 31,
                                       2008      2007      2008       2007
    Revenues:
      Collaboration revenue -
       related party                 $4,247   $12,573    $9,815    $64,751
      Other revenue                      21        29       234      3,277
        Total revenues                4,268    12,602    10,049     68,028

    Operating expenses (1):
      Cost of sales                     479     1,487     1,745      2,001
      Research and development       11,949    20,294    53,887     85,839
      Selling, general and
       administrative                 5,702     9,278    27,130     63,348
      Restructuring and
    
'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
9. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
10. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
11. Idenix to Host Conference Call Discussing Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... SEATTLE , Aug. 27, 2014  ARCH ... venture firms investing in the development of seed ... its eighth venture fund closed with more than ... exceeded its $250 million subscription target by more ... Fund VIII shows the strength and potential of ...
(Date:8/27/2014)... 27, 2014 According to the 2013 ... reshape the look and feel of markets for raw ... higher-quality ingredients will push for more branded, science-backed products.” ... experienced strong market growth in the last decade as ... food and cosmetics to fit a more ‘wellness’ lifestyle ...
(Date:8/26/2014)...  NeuroSigma, Inc., a Los Angeles ... today announced that it has filed a registration statement ... Commission relating to a proposed initial public offering of ... offered and the price range for the proposed offering ... will act as the book-running manager for the proposed ...
(Date:8/26/2014)... has just been added to the growing case ... the next big thing in the high-tech world ... An international collaboration of researchers led by a ... Lawrence Berkeley National Laboratory (Berkeley Lab) has reported ... in photo-excited MX2 materials. The recorded charge transfer ...
Breaking Biology Technology:Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3Competition for graphene 2
... StopAfib.org, at, http://www.StopAfib.org, announces that September is Atrial ... called afib or AF., Once considered benign, this ... or stroke. Every five minutes, someone in the,U.S. has ... killer and the #1 cause of,permanent disability, and takes ...
... Signalife, Inc. (Amex:,SGN) announced earlier today that breaking ... the market, regarding the law firm of Vianale ... Inc. is a life sciences company focused on ... biomedical signal,monitoring. Signalife uses its patented signal technology ...
... to InterMune - ... program in Phase 2 -, BRISBANE, Calif., Sept. 2 ... has earned a $15 million,development milestone under its development collaboration ... compound ITMN-191,(referred to as R7227 at Roche), currently in a ...
Cached Biology Technology:Atrial Fibrillation Month - StopAfib.org Announces September Focus on Life-Threatening Irregular Heartbeat 2Signalife to Issue Breaking News Regarding Vianale & Vianale Tomorrow 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 3InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 4
(Date:8/26/2014)... University in St. Louis have developed algorithms to identify ... tearing or breaking. The technology, which needs to be ... may help pinpoint minor strains and tiny injuries in ... The research is available online Aug. 27 in the ... publishes research at the nexus of the physical and ...
(Date:8/26/2014)... a New Zealand endemic tree has for the last 31 ... ,weedy, Australian shrubs and small trees. A New Zealand botanist ... discover astonishing cryptic diversity behind what was long considered a ... access journal PhytoKeys . , Known to ... of the many discoveries made in the north-western South Island ...
(Date:8/26/2014)... Unregulated trash burning around the globe is pumping far ... records. A new study led by the National Center ... of the world,s garbage is burned in such fires, ... health and climate change. , The new study provides ... pollutants such as particulates, carbon monoxide, and mercury that ...
Breaking Biology News(10 mins):New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 2And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 3Trash burning worldwide significantly worsens air pollution 2Trash burning worldwide significantly worsens air pollution 3
... Institute of General Medical Sciences, part of the National ... of Infectious Disease Agent Study for a research project ... by Stephen Eubank, professor. Infectious diseases pose one ... The Models of Infectious Disease Agent Study (MIDAS) is ...
... professor John Graves of the Virginia Institute of Marine Science ... threatened and in need of further protection. The team,s ... Policy Forumis the first study of global tuna and billfish ... of Nature (IUCN). ,The IUCN Red List is the worldwide ...
... evidence presented by a team led by Indiana University ... States as the single geographic domestication site of modern ... Proceedings of the National Academy of Sciences include Blackman,s ... and four others from Rieseberg,s lab, as well as ...
Cached Biology News:National Institutes of Health renews successful infectious disease research study 2National Institutes of Health renews successful infectious disease research study 3Study helps assess global status of tuna and billfish stocks 2Study helps assess global status of tuna and billfish stocks 3Team led by IU biologists confirms sunflower domesticated in US, not Mexico 2Team led by IU biologists confirms sunflower domesticated in US, not Mexico 3
Fluorescence Preserving Media, 100 mL...
Antibodies were affinity purified using epitopes specific to XLF immobilized on solid support....
...
... Clone/PAD: 3B8A10. Immunogen: ... the C-terminal region of ... Specific for the human ... Human (positive control: 293 ...
Biology Products: